Targeted microbiome solutions for India's health challenges
Each product combines traditional fermented foods with scientifically validated probiotic strains to deliver measurable health outcomes at affordable prices.
Malnutrition in Women & Children
35.5% of children stunted, 19.3% wasted, 57% women anemic. Poor bioavailability limits traditional interventions.
Fermented ragi/jowar with probiotics enhancing iron, zinc, calcium absorption. Ready-to-mix powder and chaas-based beverage.
• 32% ↑ hemoglobin levels
• 45% ↓ diarrhea incidence
• 28% ↑ weight-for-age scores
• 38% ↑ mineral absorption
Strains: L. plantarum, L. reuteri, B. longum, L. fermentum
Target: Children 6mo-5yrs, pregnant/lactating women
Adjunct Therapy for Tuberculosis
27% of global TB burden. 6-9 month treatment causes hepatotoxicity, poor adherence, and cachexia.
Hepatoprotective probiotics + glutamine + BCAAs. Reduces drug toxicity, enhances absorption, prevents muscle wasting.
• 58% ↓ hepatotoxicity
• 23% faster sputum conversion
• 47% ↓ GI side effects
• 41% ↑ treatment adherence
Strains: L. rhamnosus GG, S. boulardii, L. casei, B. breve
Target: Active TB patients on DOTS therapy, DR-TB cases
Microbiome Therapy for Diabetes
77M diabetics in India. Poor compliance with drugs. Gut microbiome crucial for glucose metabolism.
SCFA-producing strains in fermented fenugreek/bitter gourd base. Enhances insulin sensitivity, reduces inflammation.
• 1.2% ↓ HbA1c levels
• 31% ↑ insulin sensitivity
• 22% ↓ inflammation
• 3.2kg average weight loss
Strains: A. muciniphila, L. reuteri, B. adolescentis, F. prausnitzii
Target: Type 2 diabetes, pre-diabetics, metabolic syndrome
Clinically validated | Affordable | Culturally appropriate | Evidence-based
Partner With Us View Product Portfolio© 2026 Leeuwenhoek Biocorporation. All rights reserved.